Waters Corporation Unveil New Technology Solutions for Increasing Clinical Laboratory Efficiencies

Waters Corporation today unveiled new technology solutions for increasing clinical laboratory efficiencies including the first CE Marked LC/MS/MS integrated solution for the quantification of everolimus (Certican®).

Being displayed in Waters booth #3136 are these exciting new products.

•MassTrak™ Online Solid Phase Extraction Analyzer providing automated sample clean-up, concentration, and extraction complemented by Waters® ACQUITY® TQD tandem quadrupole mass spectrometer for high-sensitivity quantitative analysis.

•MassTrak Immunosuppressants XE Kit – CE marked in accordance with the IVD Directive 98/79/EC for the quantification of tacrolimus (FK506;Prograf®) in liver and kidney transplant patients and everolimus (Certican®)
Educational Workshops

This year, Waters is sponsoring two scientific workshops which are designed to further the education of laboratory technicians, scientists, and chemists responsible for developing, implementing, and maintaining robust clinical assays. Each workshop features presentations from leading practitioners in the field of clinical chemistry.

•Good Method Development and Validation Practices for Liquid Chromatography – Mass Spectrometry (LC-MS)
Tuesday, July 26, 6 – 7:30 p.m., Hyatt Regency Atlanta, Regency Ballroom VII.

•Implementing LC/MS/MS in the Clinical Laboratory, Wednesday, July 27, 6 – 7:30 p.m., Hyatt Regency Atlanta, Centennial Ballroom III.

Scientific Posters

Waters scientists and customers will be presenting several scientific posters at AACC including:

•Everolimus Measurement: Evaluating the Waters MassTrak Immunosuppressant XE Kit for use with LC/MS/MS
•Development of a Rapid Quantitative/Semi-Quantitative LC/MS/MS Method to Monitor Opioids and Glucuronide Metabolites
•Measurement of 25-Hydroxyvitamin D3 and C3-epi-25-Hydroxyvitamin D3 Using UPLC/MS/MS in Pediatric and Adult Populations
•Evaluation of LC/MS/MS Scrambling Ratios for Deuterium-Labeled Vitamin D Metabolites, Steroids and Other Compounds of Clinical Significance
•Development of an LC/MS/MS Method for 1,25 Dihydroxy Vitamin D for Use in the Clinical Laboratory